Réka Angi

Development of an abiraterone acetate formulation with improved oral bioavailability guided by absorption modeling based on in vitro dissolution and permeability measurements

Tamás Solymosi, Zsolt Ötvös, Réka Angi et al. · International Journal of Pharmaceutics · 2017 · 29 citations

Abiraterone Acetate Formulation, Pharmaceutical Science, Improved Oral Bioavailability +5

Novel continuous flow technology for the development of a nanostructured Aprepitant formulation with improved pharmacokinetic properties

Réka Angi, Tamás Solymosi, Zsolt Ötvös et al. · European Journal of Pharmaceutics and Biopharmaceutics · 2013 · 28 citations

Nanostructured Aprepitant Formulation, Nanomedicine, Improved Pharmacokinetic Properties +10

Novel formulation of abiraterone acetate might allow significant dose reduction and eliminates substantial positive food effect

Tamás Solymosi, Zsolt Ötvös, Réka Angi et al. · Cancer Chemotherapy and Pharmacology · 2017 · 26 citations

Pharmacological Study, Active Ingredient, Abiraterone Acetate +6

Solubility Measurements at 296 and 310 K and Physicochemical Characterization of Abiraterone and Abiraterone Acetate

Tamás Solymosi, Ferenc Tóth, János Orosz et al. · Journal of Chemical & Engineering Data · 2018 · 24 citations

Medicinal Chemistry, Physicochemical Characterization, Pharmaceutical Science +14

Investigations of the mechanism behind the rapid absorption of nano-amorphous abiraterone acetate

Orsolya Basa-Dénes, Tamás Solymosi, Zsolt Ötvös et al. · European Journal of Pharmaceutical Sciences · 2019 · 19 citations

Materials Science, Chemical Engineering, Engineering +6